Avidity Biosciences, Inc. (NASDAQ:RNA) Given Consensus Ratin

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has earned an average rating of “Buy” from the six analysts that are currently covering the company, Marketbeat.com reports. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokerages […]

Related Keywords

Arizona , United States , American , , American International Group Inc , Nasdaq , Daiwa Securities Group Inc , Group Plc , Wells Fargo Company , Ameritas Investment Partners Inc , Avidity Biosciences Company Profile , Avidity Biosciences Inc , Avidity Biosciences , Get Free Report , General Group Plc , State Retirement System , Securities Group , Investment Partners , American International Group , International Group , Get Free , Avidity Biosciences Daily , Nasdaq Rna , Rna , Medical , Ratings , Consensus ,